Jolliet P. | Clinical Pharmacology Department Chu De Nantes
スポンサーリンク
概要
関連著者
-
Jolliet P.
Clinical Pharmacology Department Chu De Nantes
-
DAILLY E.
Clinical Pharmacology Department, CHU de Nantes
-
RAFFI F.
Infectious Diseases Department, CHU de Nantes
-
Raffi F.
Infectious Diseases Department Chu De Nantes
-
Dailly E.
Clinical Pharmacology Department Chu De Nantes
-
RELIQUET V.
Infectious Diseases Department, CHU de Nantes
-
Reliquet V.
Infectious Diseases Department Chu De Nantes
-
KERGUERIS M.
Laboratoire de Pharmacologie Clinique, Institut de Biologie, Centre Hospitalier Universitaire
-
BOURIN M.
Laboratoire de Pharmacologie Clinique, Institut de Biologie, Centre Hospitalier Universitaire
-
Bourin M.
Laboratoire De Pharmacologie Clinique Institut De Biologie Centre Hospitalier Universitaire
-
DAILLY E.
Laboratoire de Pharmacologie Clinique, Institut de Biologie, Centre Hospitalier Universitaire
-
THOMAS L.
Laboratoire de Pharmacologie Clinique, Institut de Biologie, Centre Hospitalier Universitaire
-
JOLLIET P.
Laboratoire de Pharmacologie Clinique, Institut de Biologie, Centre Hospitalier Universitaire
-
MARTIN J.
Clinical Pharmacology Department, CHU de Nantes
-
DESLANDES G.
Clinical Pharmacology Department, CHU de Nantes
-
RENAUD C.
Clinical Pharmacology Department, CHU de Nantes
-
VICTORRI-VIGNEAU C.
Clinical Pharmacology Department, Hotel Dieu
-
Renaud C.
Clinical Pharmacology Department Chu De Nantes
-
Deslandes G.
Clinical Pharmacology Department Chu De Nantes
-
Victorri-vigneau C.
Clinical Pharmacology Department Hotel Dieu
-
Kergueris M.
Laboratoire De Pharmacologie Clinique Institut De Biologie Centre Hospitalier Universitaire
-
Martin J.
Clinical Pharmacology Department Chu De Nantes
著作論文
- High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid e
- A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV
- A simple high performance liquid chromatography assay for monitoring plasma concentrations of tipranavir in HIV infected patients
- Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detecti